New Products In Brief
Vicks gets tough on mucus: Procter & Gamble extends its Vicks DayQuil line with two mucus-controlling liquids, the company announced Dec. 23. DayQuil Mucus Control helps loosen mucus for up to four hours, the Cincinnati company said, while DayQuil Mucus Control DM contains the cough suppressant dextromethorphan. Both products are sold in 6-ounce and 10-ounce bottles at suggested retail prices between $6.49 and $7.29. The stock-keeping units each contain 200 mg of guaifenesin, compared to 600 mg of the expectorant in Reckitt Benckiser's Mucinex
More from Archive
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
New plan to encourage alternatives to animal testing seeks interagency cooperation to meet more aggressive targets for transformational change than the US FDA’s long-standing program.
HHS Secretary Robert F. Kennedy Jr. urged FDA staff to resist the “deep state” and “crony capitalism,” and focus on improving the health of America’s children. “You're not here to take orders,” he said and urged FDA staff to speak up if they see wrongdoing.
Antabio’s next-generation, broad-spectrum antibacterial, MEM-ANT3310, has made it onto the European Medicines Agency’s priority medicines scheme. The company says its product is designed to make a significant impact on the growing problem of antimicrobial resistance.